Orchard Therapeutics PLC Sponsored ADR Net Profit Margin 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR net profit margin from 2019 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-09-30 | $0.02B | $-0.07B | -342.86% |
| 2023-06-30 | $0.02B | $-0.09B | -404.76% |
| 2023-03-31 | $0.02B | $-0.12B | -688.89% |
| 2022-12-31 | $0.02B | $-0.15B | -656.52% |
| 2022-09-30 | $0.02B | $-0.18B | -1118.75% |
| 2022-06-30 | $0.01B | $-0.17B | -1518.18% |
| 2020-09-30 | $0.00B | $-0.16B | -4100.00% |
| 2020-06-30 | $0.00B | $-0.18B | -4525.00% |
| 2019-09-30 | $0.00B | $-0.14B | -4800.00% |
